Two months swiftly passed by, and the ADT series of drugs were sent to the FDA for preliminary testing. Under the pressure from the thirteen major investment tycoons, the clinical trials for the drugs were expected to be completed at the fastest speed. However, even before that, the highly reputable ADT was already making waves in American high society through whispers among the thirteen investors.
Much to Chen Yang's surprise, he had initially assumed that by setting the price of ADT-210 at twelve thousand US dollars per tablet and not limiting its production, there would not be many buyers. But he had underestimated the potential of American high society. Despite controlled production, many people were completely unaware of the ADT-210 series. For those who did know about it, despite hiking up the price tenfold, no one was willing to sell theirs.
